Country intelligence
Deals, market moves, science and policy across the platform tagged to Ukraine.
Medical access legalised in 2024 — a significant emerging Eastern European market.
Market sizing, forecasts, pricing and patient data are available to Prohibition Partners subscribers. View on Prohibition Partners →
The 2024 Cannabis Law removed cannabis resin and extract from the dangerous-substances list, allowing licensed cultivation, manufacturing, trade and dispensation. With domestic cultivation some years off, import procedures for API have been eased; the market is currently extract-only.
Both primary-care and specialist doctors can prescribe, subject to approval by a medical advisory committee, for an approved list including chronic and neuropathic pain and spasticity, chemotherapy nausea, Parkinson's, Tourette's and several epilepsy syndromes.
There is currently no reimbursement for medical cannabis.
Nothing tagged to Ukraine yet. Tag deals, studies or articles with this country to see them here and on the map.
